Clinical Trials Logo

Clinical Trial Summary

Mediastinitis are rare but serious infections, with mortality rates varying from 6 to 30% according to the literature. They are essentially linked to surgical management (cardio-thoracic in particular), but some forms can be spontaneous, after extension of an ENT infectious focus, for example. Despite their seriousness, there is no strong recommendations to define their management, especially concerning antibiotic therapy and its duration. The aim of this research is to make a descriptive analysis of the cases of mediastinitis at HUS in recent years, and to study the therapeutic strategy used


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05001308
Study type Observational
Source University Hospital, Strasbourg, France
Contact Yvon RUCH, MD
Phone 33 3 69 55 12 19
Email yvon.ruch@chru-strasbourg.fr
Status Recruiting
Phase
Start date June 1, 2021
Completion date May 31, 2022

See also
  Status Clinical Trial Phase
Completed NCT02513576 - Physiotherapy Exercises in Patients With Sternal Instability After Cardiovascular Surgery N/A
Completed NCT00819286 - Evaluation of Primary Plating in Sternotomy Patients for Osteosynthesis and Pain N/A
Completed NCT00638014 - Rapid Sternal Closure System (TALON) Phase 4
Completed NCT04617353 - Combined Air-plasma Flow and Nitric Oxide Therapy in Cardiac Surgery N/A
Completed NCT02073760 - Optimizing Prevention of Healthcare-Acquired Infections After Cardiac Surgery (HAI)_2
Not yet recruiting NCT01473979 - Delayed Primary Versus Late Secondary Wound Closure in Sternum Infections N/A
Recruiting NCT00876551 - Endoscopic-vacuum Assisted Closure of Intrathoracic Postsurgical Leaks N/A
Completed NCT03961503 - Retrospective Analysis of Nephrotoxicity During Daptomycin Versus Vancomycin Treatments in High Risk Patients
Completed NCT04865003 - Prognostic Factors for Descending Necrotizing Mediastinitis Development in Deep Space Neck Infections
Completed NCT03922191 - Post-Surgical Mediastinitis Within the CHU Brugmann Hospital
Terminated NCT00518687 - Efficacy, Immunogenicity, and Safety of a Single Dose of V710 in Adult Patients Scheduled for Cardiothoracic Surgery (V710-003 AM2) Phase 2/Phase 3